NKGen Biotech (NKGN) Institutional Ownership $0.14 -0.03 (-17.65%) As of 08/8/2025 12:03 PM Eastern Add Compare Share Share Ownership Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for NKGen Biotech (NYSE:NKGN)CurrentInstitutional OwnershipPercentage76.17%Number ofInstitutional Buyers(last 12 months)6TotalInstitutional Inflows(last 12 months)$478.28KNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$934.03K Get NKGN Insider Trade Alerts Want to know when executives and insiders are buying or selling NKGen Biotech stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data NKGN Institutional Buying and Selling by Quarter NKGen Biotech Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/8/2025 University of Chicago325,000$58K0.1%-40.9%0.723% 2/25/2025Polar Asset Management Partners Inc.500,000$328K0.0%-57.7%1.112% 2/17/2025Polar Asset Management Partners Inc.500,000$328K0.0%-57.7%1.112% 2/13/2025Advisory Research Inc.43,088$28K0.0%N/A0.096% 2/12/2025Geode Capital Management LLC127,168$83K0.0%+12.8%0.283% 2/11/2025Kepos Capital LP230,022$151K0.2%N/A0.512% 2/11/2025Magnetar Financial LLC267,508$175K0.0%N/A0.595% 2/7/2025 Sequoia Financial Advisors LLC156,000$102K0.0%+126.1%0.347% 11/15/2024Polar Asset Management Partners Inc.1,181,872$447K0.0%+9.4%3.342% 10/22/2024 Sequoia Financial Advisors LLC69,000$26K0.0%+273.0%0.268% 5/1/2024 Sequoia Financial Advisors LLC16,000$30K0.0%N/A0.070% 3/14/2024 University of Chicago550,000$1.51M2.1%N/A2.513% (Data available from 1/1/2016 forward) NKGN Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of NKGN shares? During the previous two years, the following institutional investors and hedge funds held shares of NKGen Biotech shares: Polar Asset Management Partners Inc. ($328K), Magnetar Financial LLC ($175K), Kepos Capital LP ($151K), Sequoia Financial Advisors LLC ($102K), Geode Capital Management LLC ($83K), and University of Chicago ($58K), and Advisory Research Inc. ($28K).Learn more on NKGen Biotech's institutional investors. What percentage of NKGen Biotech's stock is owned by institutional investors? 76.17% of NKGen Biotech's stock is owned by institutional investors. Learn more on NKGN's institutional investor holdings. Which institutional investors have been buying NKGen Biotech's stock? The following institutional investors have purchased NKGen Biotech's stock in the last 24 months: University of Chicago ($550K), Magnetar Financial LLC ($267.51K), Kepos Capital LP ($230.02K), Sequoia Financial Advisors LLC ($153.50K), Polar Asset Management Partners Inc. ($101.87K), Advisory Research Inc. ($43.09K), and Geode Capital Management LLC ($14.45K). How much institutional buying is happening at NKGen Biotech? Institutional investors have bought a total of 794,444 shares in the last 24 months. This purchase volume represents approximately $478.28K in transactions. Which of NKGen Biotech's major shareholders have been selling company stock? The following institutional investors have sold NKGen Biotech stock in the last 24 months: Polar Asset Management Partners Inc. ($1.36M), and University of Chicago ($225K). How much institutional selling is happening at NKGen Biotech? Institutional investors have sold a total of 1,588,744 shares in the last 24 months. This volume of shares sold represents approximately $934.03K in transactions. Related Companies Dyadic International Major Shareholders Iterum Therapeutics Major Shareholders Estrella Immunopharma Major Shareholders Kezar Life Sciences Major Shareholders OnKure Therapeutics Major Shareholders Cingulate Major Shareholders FibroGen Major Shareholders Tempest Therapeutics Major Shareholders SCYNEXIS Major Shareholders MIRA Pharmaceuticals Major Shareholders This page (NYSE:NKGN) was last updated on 8/9/2025 by MarketBeat.com Staff From Our PartnersYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NKGen Biotech, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NKGen Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
